16 min

Vaccine management during a global pandemic International Hospital Federation

    • Non-Profit

For the 3rd episode of the WHC Podcast series, Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers & Associations, shares light on vaccine management during a global pandemic. He further emphasized how the collaboration between government and pharmaceutical companies is different for the COVID-19 vaccines.

Thomas Cueni is the Director-General of the International Federation of Pharmaceutical Manufacturers & Associations - the global association of pharmaceutical research companies and Secretary of the global Biopharmaceutical CEO Roundtable. He was instrumental in creating the AMR Action Fund, a ground-breaking partnership that has raised nearly $1 billion to bring 2-4 new antibiotics to patients by 2030. He also Chairs the Business at OECD Health Committee and the Board of the cross-sectoral AMR Industry Alliance. He represents the innovative biopharmaceutical industry on the Access to COVID-19 Tools (ACT) Accelerator - a unique global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines.

For the 3rd episode of the WHC Podcast series, Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers & Associations, shares light on vaccine management during a global pandemic. He further emphasized how the collaboration between government and pharmaceutical companies is different for the COVID-19 vaccines.

Thomas Cueni is the Director-General of the International Federation of Pharmaceutical Manufacturers & Associations - the global association of pharmaceutical research companies and Secretary of the global Biopharmaceutical CEO Roundtable. He was instrumental in creating the AMR Action Fund, a ground-breaking partnership that has raised nearly $1 billion to bring 2-4 new antibiotics to patients by 2030. He also Chairs the Business at OECD Health Committee and the Board of the cross-sectoral AMR Industry Alliance. He represents the innovative biopharmaceutical industry on the Access to COVID-19 Tools (ACT) Accelerator - a unique global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines.

16 min